← Open Payments lookup

LINDSAY GREGG: Open Payments

NPI 1700563913 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,758 in 120 payments from 20 companies in 2025. Trend: 2023 $227 · 2024 $1,218 · 2025 $1,758

Food & beverage: $1,698Education: $61
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.22$334
Supernus Pharmaceuticals, Inc.22$213
Neurocrine BioSciences, Inc.15$205
Otsuka America Pharmaceutical, Inc.12$178
ABBVIE INC.11$175
Alkermes, Inc.10$156
Teva Pharmaceuticals USA, Inc.5$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Axsome Therapeutics, Inc.4$67
Lundbeck LLC3$58

Products named: FANAPT, Qelbree, INGREZZA, REXULTI, VRAYLAR, ARISTADA, AUSTEDO XR, CAPLYTA.

Industry payments across IN — which companies pay providers there.